ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Hematology

Top Hematology Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANJU GURUNG

Hematology

5,678

$233K

317
258 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $279

MARIUS MOKWE M.D.

Hematology

3,432

$185K

118
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $279

JAYA KASTURI M.D.

Hematology

3,112

$209K

106
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $279

HELEN GUE MD

Hematology

2,841

$187K

105
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $279

JAYESH MEHTA MD

Hematology

2,448

$1.27M

208
148 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$519
Average prescription price

Avg: $279

MICHAEL ELLISON MD

Hematology

1,712

$91.9K

145
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $279

LYNNE KAMINER MD

Hematology

942

$893K

111
101 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$948
Average prescription price

Avg: $279

DAVID GRINBLATT MD

Hematology

735

$1.27M

83
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 24%

$1730
Average prescription price

Avg: $279

OLGA FRANKFURT MD

Hematology

594

$1.39M

56
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 24%

$2339
Average prescription price

Avg: $279

JOHN MACIEJEWSKI M.D.

Hematology

486

$154K

53
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 24%

$317
Average prescription price

Avg: $279

ANAADRIANA ZAKARIJA MD

Hematology

475

$173K

46
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$365
Average prescription price

Avg: $279

SEEMA SINGHAL MD

Hematology

392

$56.8K

60
46 are 65+

25%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $279

ROBERT STEIN MD

Hematology

305

$410K

59
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 24%

$1343
Average prescription price

Avg: $279

JANE WINTER MD

Hematology

187

$5,000

40
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 24%

$27
Average prescription price

Avg: $279

SEFER GEZER M.D.

Hematology

164

$32.2K

30
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$196
Average prescription price

Avg: $279

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank